Finance

Beta
Ask
Lists
511654:BOM
Sugal and Damani Share Brokers Ltd
₹62.50
+1.46%
(+0.90) 1D
Jun 19, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 511654...
Open
₹62.21
High
₹62.95
Low
₹62.21
Mkt. cap
390.63M
Avg. vol.
1.35K
Volume
36.00
P/E ratio
9.46
52-wk high
₹139.00
52-wk low
₹51.25
EPS
₹6.61
No. of employees
25
Open
₹62.21
High
₹62.95
Low
₹62.21
Mkt. cap
390.63M
Avg. vol.
1.35K
Volume
36.00
P/E ratio
9.46
52-wk high
₹139.00
52-wk low
₹51.25
EPS
₹6.61
No. of employees
25
News stories
From sources across the web
About Sugal and Damani Share Brokers Ltd
CEO-
Employees25
Founded1993
Headquarters-
SectorCapital market
Websitesugalshare.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-156.60M
63.69M
61.56M
24.25M
Cost of goods sold
45.43M
28.96M
37.99M
16.20M
Cost of revenue
45.43M
28.96M
37.99M
16.20M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.07M
5.82M
4.70M
3.59M
Operating expense
-44.40M
7.84M
6.34M
5.91M
Total operating expenses
1.03M
36.80M
44.32M
22.12M
Operating income
-157.63M
26.89M
17.23M
2.14M
Other non operating income
41.00K
-
-
-
EBT including unusual items
22.14M
26.89M
17.23M
2.14M
EBT excluding unusual items
-157.59M
26.89M
17.23M
2.14M
Income tax expense
5.86M
6.50M
4.10M
500.00K
Effective tax rate
26.45%
24.17%
23.79%
23.40%
Other operating expenses
-51.66M
1.80M
1.41M
2.09M
Net income
16.28M
20.39M
13.13M
1.64M
Net profit margin
-10.40%
32.01%
21.34%
6.75%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
193.00K
213.00K
230.00K
237.00K
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer